Cutler Group LP Veracyte, Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2018 Aug 10, 2018	SELL	$5.39 - $9.66 $13,475 - $24,150	-2,500 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$5.44 - $6.97 $29,920 - $38,335	-5,500 Reduced 68.75%	2,500 $6,000
Q4 2017 Jan 17, 2018	SELL	$6.05 - $9.37 $308,550 - $477,869	-51,000 Reduced 86.44%	8,000 $24,000
Q3 2017 Oct 17, 2017	BUY	$7.81 - $8.77 $460,790 - $517,430	59,000	59,000 $71,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.